Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market
Medical Equipment

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Trends And Growth Outlook Across The 2026–2030 Forecast Period

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Does The Forecasted Market Size Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Compare Between 2026 And 2030?

The benign prostatic hyperplasia (bph) treatment devices and equipment market size has demonstrated significant growth in recent years. This market is projected to expand from $1.34 billion in 2025 to $1.43 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.3%. Historically, this growth can be attributed to the rising prevalence of benign prostatic hyperplasia, increased awareness regarding urological disorders, the adoption of transurethral procedures, the expansion of hospital urology departments, and enhancements in endoscopic surgical tools.

The benign prostatic hyperplasia (bph) treatment devices and equipment market size is projected to experience substantial growth in the upcoming years. It is foreseen to expand to $1.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.9%. This anticipated growth during the forecast period is attributed to the increasing aging male population, a rising preference for minimally invasive therapies, the expansion of outpatient urology clinics, the growing adoption of laser and implant-based treatments, and an increasing focus on reduced hospital stays. Significant trends during this period include the increasing adoption of minimally invasive bph treatment devices, a rising use of laser-based prostate therapies, the growing demand for implant-based treatment options, the expansion of office-based bph procedures, and an enhanced focus on patient comfort and recovery.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

Which Strategic Drivers Are Supporting The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Development?

The benign prostatic hyperplasia market is projected to grow due to the increasing number of prostate cancer cases. Prostate cancer is a type of malignancy that develops in the prostate gland, a small, walnut-sized organ found just below the bladder in men. A rise in prostate cancer diagnoses often results in a greater number of older men seeking medical attention for prostate-related issues. This consequently leads to the identification and management of benign prostatic hyperplasia. For instance, in February 2023, according to the American Society of Clinical Oncology (ASCO), a US-based professional organization that publishes patient information on the cancer.net website, there were an estimated 288,300 men in the United States with prostate cancer in 2023, and in 2022, there were 268,490 new cases and 34,500 deaths from prostate cancer. Therefore, the increase in prostate cancer cases is fueling the growth of the benign prostatic hyperplasia market.

How Is The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Examined Through Segment Analysis?

The benign prostatic hyperplasia (bph) treatment devices and equipment market covered in this report is segmented –

1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants

2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types

3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Specialty Urology Centers

Subsegments:

1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes

2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation

3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers

4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents

5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment

Which Trends Are Influencing The Expansion Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?

Companies operating within the benign prostatic hyperplasia (BPH) treatment devices and equipment market are concentrating on creating inventive, less invasive approaches, such as devices that are temporarily implantable. These innovations aim to broaden access to outpatient care and lessen dependence on ongoing medication or procedures involving tissue removal. Temporarily implantable BPH devices are designed for single or short-term use, functioning to reshape the prostatic urethra and alleviate lower urinary tract symptoms (LUTS) associated with an enlarged prostate. For example, in February 2025, Olympus, a medical technology firm based in Japan, announced a significant expansion for its iTind device, making it available in key APAC markets including Thailand, Australia, Hong Kong, Singapore, and India, with a launch planned for Korea. The company emphasized that the iTind procedure offers a minimally invasive, clinic-based treatment option, performable under local anaesthesia, and is supported by an extensive physician training program to facilitate its clinical integration. The iTind device itself is a temporarily implantable nitinol structure that reconfigures the prostatic urethra, thereby enhancing urinary flow and improving patients’ quality of life, with recent updates in guidelines and reimbursement significantly boosting its acceptance.

Which Companies Are Engaged In The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Environment?

Major companies operating in the benign prostatic hyperplasia (bph) treatment devices and equipment market are Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston Scientific Inc., NeoTract Inc., OmniGuide Inc., ProArc Medical Ltd., Urotech Devices, Prostalund Operations AB, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, PROCEPT BioRobotics, Quanta System

Access The Complete Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report:

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Which Regional Market Leads The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?

North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2025. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (bph) treatment devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=2431&type=smp

Browse Through More Reports Similar to the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market 2026, By The Business Research Company

Drugs For Benign Prostatic Hypertrophy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-benign-prostatic-hypertrophy-global-market-report

Prostate Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report

Prostate Cancer Nuclear Medicine Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/prostate-cancer-nuclear-medicine-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model